The next year, Congress passed The Inflation Reduction Act, which included a provision capping insulin prices for seniors on Medicare. As a result Sanofi, Novo Nordisk and Eli Lilly capped their co-pays at $35, but only for Medicare patients. The Cap Inflation Prices Act was introduced in ...